Rita Jain - 27 Mar 2022 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role: EVP, Chief Medical Officer, Director
Signature: /s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol: CCXI
Transactions as of: 27 Mar 2022
Transactions value $: $0
Form type: 4
Filing time: 29 Mar 2022, 19:50:16 UTC
Previous filing: 24 Feb 2022
Next filing: 24 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCXI	Common Stock	Options Exercise	$0	+5,251	+22.94%	$0	28,137	27 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CCXI	Restricted Stock Units	Options Exercise		-5,251	-100%		0	27 Mar 2022	Common Stock	5,251		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were acquired upon vesting of restricted stock units awarded on March 27, 2019.
F2	Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F3	The restricted stock units awarded on March 27, 2019, vest in three equal installments on March 27, 2020, March 27, 2021, and March 27, 2022, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.